Sort   by:  
 Page size 
UnknownStaged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease.
Not available
S-EPMC11889527 | biostudies-literature
UnknownNeuronal α-Synuclein Disease Stage Progression over 5 Years.
Not available
S-EPMC12273616 | biostudies-literature
UnknownImmunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4).
Not available
S-EPMC6097838 | biostudies-literature
UnknownEarly Outcomes of SARS-CoV-2 Infection in a Multisite Prospective Cohort of Inpatient Veterans.
Not available
S-EPMC10358428 | biostudies-literature
UnknownDisease modification and biomarker development in Parkinson disease: Revision or reconstruction?
Not available
S-EPMC7220234 | biostudies-literature
UnknownNeuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.
Not available
S-EPMC11567150 | biostudies-literature
UnknownUnderstanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
Not available
S-EPMC7657351 | biostudies-literature
UnknownAn analysis-ready and quality controlled resource for pediatric brain white-matter research.
Not available
S-EPMC9556519 | biostudies-literature
UnknownEffect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study.
Not available
S-EPMC8492020 | biostudies-literature
UnknownGlobal Burden of Cardiovascular Diseases and Risks, 1990-2022.
Not available
S-EPMC7615984 | biostudies-literature
Sort   by:  
 Page size